The p53 codon 72 polymorphism and lung cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 9, Issue 10, 2000, Pages 1037-1042

  Fan, R ^a   Wu, M T ^a   Miller, D ^a   Wain, J C ^a   Kelsey, K T ^a   Wiencke, J K ^a   Christiani, D C ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; PROLINE;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; AGED; CASE-CONTROL STUDIES; FEMALE; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMAN; LUNG NEOPLASMS; MALE; MIDDLE AGE; POLYMERASE CHAIN REACTION; POLYMORPHISM (GENETICS); RISK ASSESSMENT; SMOKING; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0033792295     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Codon 72 polymorphism of the Tp53 gene
2. p53 Mutations in human cancers
3. How p53 suppresses cell growth
4. 1 arrest
5. Tumor suppressor genes
6. The importance of p53 gene alterations in human cancer: Is there more than circumstantial evidence?
7. p53 Function and dysfunction
8. p53: The promising story continues to unfold
9. p53: At the crossroads of molecular carcinogenesis and risk assessment
10. Transactivation of the human p53 tumor suppressor gene by c-myc/max contributes to elevated mutant p53 expression in some tumors
11. Detection of loss of heterozygosity in the p53 gene in renal cell carcinoma and bladder cancer using the polymerase chain reaction
12. Primary structure polymorphism at amino acid residue 72 of human p53
13. Allelic frequency of a p53 polymorphism in human lung cancer
14. Determination of the allele frequencies of an L-myc and a p53 polymorphism in human lung cancer
15. 1. Germ line polymorphism of p53 and CYPIAI genes involved in human lung cancer
16. Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype
17. P53 polymorphisms and haplotypes in lung cancer
18. Glutathione-S-Transferase Ml, and codon 72 p53 polymorphism in a northwestern Mediterranean population and their relation to lung cancer susceptibility
19. Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history
20. Epidemiology standardized project
21. Host factors in lung cancer risk: A review of interdisciplinary studies
22. Genetic polymorphism and cancer susceptibility: Fourteenth Sapporo Cancer Seminar
23. The CYPIAI gene and cancer susceptibility
24. An epidemiological approach to ecogenetics
25. Risk assessment, pharmacogenetics and ecogenetics
26. Two polymorphic variants of wild-type p53 differ biochemically and biologically
27. The validity of case-control studies with nonrandom selection of controls
28. p53 Codon 72 polymorphism in Taiwanese lung cancer patients: Association with lung cancer susceptibility and prognosis
29. Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California
30. Human CYPIAI gene: Cosegregation of the enzyme inducibility phenotype and an RFLP